- Business Wire•13 minutes ago
AVEO Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 30,000,000 shares of common stock at a price to the public of $0.50 per share, before underwriting discounts, which would result in aggregate gross proceeds of approximately $15 million.
- Business Wire•3 hours ago
AVEO Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- Zacks•5 days ago
AVEO Pharmaceuticals, Inc. (AVEO) reported a narrower-than-expected loss in the fourth-quarter 2016.
AVEO : Summary for AVEO Pharmaceuticals, Inc. - Yahoo Finance
AVEO Pharmaceuticals, Inc. (AVEO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||0.51 x 3700|
|Ask||0.59 x 400|
|Day's Range||0.64 - 0.68|
|52 Week Range||0.54 - 1.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.48|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|